U. Fogl

Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil.

W. Jäger, M. Czejka, M. Micksche, 1992, Seminars in oncology.

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.

G. Batist, T. Shore, F. Porzsolt, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical pharmacokinetics of 5-fluorouracil. Influence of the biomodulating agents interferon, dipyridamole and folinic acid alone and in combination.

W. Jäger, M. Czejka, G. Schernthaner, 1993, Arzneimittel-Forschung.

[Comparative bioavailability of fluorouracil and its prodrug, ftorafur, following intra-arterial, intravenous and preoral administration].

M. Czejka, J. Schüller, W. Jäger, 1991, Pharmazie.